Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neuronetics (STIM) EBIT (2017 - 2025)

Historic EBIT for Neuronetics (STIM) over the last 9 years, with Q3 2025 value amounting to -$7.3 million.

  • Neuronetics' EBIT rose 526.66% to -$7.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$37.9 million, marking a year-over-year decrease of 3758.58%. This contributed to the annual value of -$34.6 million for FY2024, which is 1312.1% down from last year.
  • As of Q3 2025, Neuronetics' EBIT stood at -$7.3 million, which was up 526.66% from -$8.1 million recorded in Q2 2025.
  • In the past 5 years, Neuronetics' EBIT registered a high of -$4.4 million during Q4 2023, and its lowest value of -$11.5 million during Q4 2024.
  • In the last 5 years, Neuronetics' EBIT had a median value of -$7.7 million in 2022 and averaged -$8.1 million.
  • Its EBIT has fluctuated over the past 5 years, first plummeted by 19628.71% in 2021, then soared by 4270.74% in 2023.
  • Neuronetics' EBIT (Quarter) stood at -$6.9 million in 2021, then fell by 11.84% to -$7.7 million in 2022, then soared by 42.71% to -$4.4 million in 2023, then plummeted by 159.14% to -$11.5 million in 2024, then soared by 36.18% to -$7.3 million in 2025.
  • Its EBIT stands at -$7.3 million for Q3 2025, versus -$8.1 million for Q2 2025 and -$11.0 million for Q1 2025.